GRAND PHARM. GRP. HD-01

Research GRAND PHARM. GRP. HD-01 (MX6A) on Bullrun: market cap EUR 1.79B, P/E 12.4, dividend yield 3.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMX6A
• ExchangeF
• CountryHong Kong
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 1.79B
• P/E12.4
• Dividend yield3.7%
• Financial periodFY2024
• RevenueEUR 11.64B
• Revenue growth10.6%
• Net incomeEUR 2.47B
• Free cash flowEUR 1.28B
• Gross margin57.9%

Valuation Snapshot

latest market cap is EUR 1.79B; P/E is 12.4; dividend yield is 3.7%.

About GRAND PHARM. GRP. HD-01

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products.

Frequently asked questions

What is GRAND PHARM. GRP. HD-01's market cap?

GRAND PHARM. GRP. HD-01's market capitalization is EUR 1.79B.

What is GRAND PHARM. GRP. HD-01's P/E ratio?

GRAND PHARM. GRP. HD-01's price-to-earnings (P/E) ratio is 12.4.

Does GRAND PHARM. GRP. HD-01 pay a dividend?

GRAND PHARM. GRP. HD-01 has a dividend yield of 3.7%.

What does GRAND PHARM. GRP. HD-01 do?

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.